CYPHERPUNK TECHNOLOGIES INC. Loss Contingency, New Claims Filed, Number
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Loss Contingency, New Claims Filed, Number of 3 claim for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency, Quantities
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2021-05-14
- CYPHERPUNK TECHNOLOGIES INC. loss contingency, new claims filed, number for the quarter ending 2021-03-31 was 3.00 claim, a 0.00% change year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. loss contingency, new claims filed, number for the quarter ending 2020-03-31 was 3.00 claim.
- CYPHERPUNK TECHNOLOGIES INC. loss contingency, new claims filed, number for fiscal 2020 was 3.00 claim, a 0.00% change from fiscal 2019.
- CYPHERPUNK TECHNOLOGIES INC. loss contingency, new claims filed, number for fiscal 2019 was 3.00 claim.
| Period end | Loss Contingency, New Claims Filed, Number 3 month | Loss Contingency, New Claims Filed, Number 6 month | Loss Contingency, New Claims Filed, Number 12 month |
|---|---|---|---|
| 2021-03-31 | 3.00 claim 10-Q · filed 2021-05-14 | ||
| 2020-12-31 | 3.00 claim 10-K · filed 2021-03-12 | ||
| 2020-06-30 | 3.00 claim 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | 3.00 claim 10-Q · filed 2020-05-14 | ||
| 2019-12-31 | 3.00 claim 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |